Elizaveta Freinkman, Ph.D.
Affiliations: | 2012 | Chemical Biology | Harvard University, Cambridge, MA, United States |
Area:
molecular mechanisms of various antibioticsGoogle:
"Elizaveta Freinkman"Mean distance: 8.43 | S | N | B | C | P |
Parents
Sign in to add mentorDaniel E. Kahne | grad student | 2012 | Harvard | |
(Assembly and Regulation of the Lipopolysaccharide Transporter.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Luengo A, Abbott KL, Davidson SM, et al. (2019) Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer. Nature Communications. 10: 5604 |
Goldman A, Khiste S, Freinkman E, et al. (2019) Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance. Science Signaling. 12 |
Li H, Ericsson M, Rabasha B, et al. (2019) 6-Phosphogluconate Dehydrogenase Links Cytosolic Carbohydrate Metabolism to Protein Secretion via Modulation of Glutathione Levels. Cell Chemical Biology |
Garcia-Bermudez J, Baudrier L, Bayraktar EC, et al. (2019) Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature |
Petrova B, Liu K, Tian C, et al. (2018) Dynamic redox balance directs the oocyte-to-embryo transition via developmentally controlled reactive cysteine changes. Proceedings of the National Academy of Sciences of the United States of America |
Kanarek N, Keys HR, Cantor JR, et al. (2018) Histidine catabolism is a major determinant of methotrexate sensitivity. Nature |
Huang NJ, Lin YC, Lin CY, et al. (2018) Enhanced phosphocholine metabolism is essential for terminal erythropoiesis. Blood |
Xu H, Lee MS, Tsai PY, et al. (2018) Ablation of insulin receptor substrates 1 and 2 suppresses-driven lung tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America |
McKenney AS, Lau AN, Somasundara AVH, et al. (2018) JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. The Journal of Clinical Investigation |
Abu-Remaileh M, Wyant GA, Kim C, et al. (2017) Lysosomal metabolomics reveals V-ATPase and mTOR-dependent regulation of amino acid efflux from lysosomes. Science (New York, N.Y.) |